[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. --------------------------------------------------------------- [The Man, Whose Crypto Trades Have Soared 1,061% ... 1,934% ... and 18,235% - All in Less Than a Year, Reveals His Next Crypto Trade](=) [Details here.]( --------------------------------------------------------------- September 9, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers of all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- [Dividends Paid Every Week- Regular as Clockwork]() I've been studying two new stocks carefully and they've both been paying dividends every week — regular as clockwork. One’s more aggressive and pays a nickel per share every Friday. The second is expected to yield 3% - 4% in the first year. And it also pays every Thursday. We can use these two new ETFs to pay for our groceries, gas or restaurant bills. Or, reinvest the dividends and quickly snowball our nest eggs to help meet our retirement goals. Today, I want to share this information with you, absolutely free. [Click here for details.]() --------------------------------------------------------------- [Palatin Technologies, PTN]() Recent Analyst Action: Joseph Pantginis, analyst at H.C. Wainwright, reiterates coverage on [Palatin Technologies (PTN)]()in the Healthcare sector with a Buy rating and a price target of $70.00 (1 day ago). - Recent Price: $6.6 - Average Analyst Price Target: $60.00 (809.09%) - Market Cap: $58.50M [TipRanks.com]() also reports that [Palatin Technologies](=)currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $60.00. The target pricing ranges from a high forecast of $70.00 down to a low forecast of $50.00. [Palatin Technologies (PTN)](’s last closing price was $6.6 which would put the average price target at $60.00. Here are 3rd party ratings for [PTN](): - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 28% (71 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Get in on This Energy Bull Run Now](=) =The S&P 500 lost more than 20% in the first half of 2022… the worst first annual half since 1970. But the S&P 500 Capped Energy Index shot UP almost 70% in the first half of 2022...and there's an easy and lucrative way to play this energy crunch. It's a set-and-forget strategy that can hand you as much as $4,804 extra income each and every month. AND with sky-high energy costs, we can expect these payouts to soar much further in the months to come. [Get all the details here.](=) --------------------------------------------------------------- [Asana, ASAN](=) Recent Analyst Action: Alex Zukin, analyst at Wolfe Research, reiterates coverage on [Asana (ASAN)](in the Technology sector with a Buy rating and a price target of $23.75 (1 day ago). - Recent Price: $24.05 - Average Analyst Price Target: $30.09 (25.11%) - Market Cap: $4.52B [TipRanks.com]() also reports that [Asana](currently has 8 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $30.09. The target pricing ranges from a high forecast of $65.00 down to a low forecast of $15.00. [Asana (ASAN)](=)’s last closing price was $24.05 which would put the average price target at $30.09. Here are 3rd party ratings for [ASAN](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Bottom 44% (140 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Dice Therapeutics, DICE]( Recent Analyst Action: Alex Thompson, analyst at Stifel Nicolaus, reiterates coverage on [Dice Therapeutics (DICE)](in the Healthcare sector with a Buy rating and a price target of $37.00 (3 days ago). - Recent Price: $22.09 - Average Analyst Price Target: $41.00 (85.60%) - Market Cap: $844.08M [TipRanks.com]() also reports that [Dice Therapeutics](=)currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $41.00. The target pricing ranges from a high forecast of $46.00 down to a low forecast of $37.00. [Dice Therapeutics (DICE)](’s last closing price was $22.09 which would put the average price target at $41.00. Here are 3rd party ratings for [DICE](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 28% (71 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [The Solution to Trading in A Tough Market (Like This One)](=) It’s easy - and fun! - to trade when the markets are reaching new highs. But those days are over (for now). With increasing chaos every week, traders are dealing with stomach-churning charts at the start of every trading day. What do you do? You need a plan. [Click HERE for the perfect stock to load up on while the trading gets tougher.]() (**By clicking link you are subscribing to The Investing Ideas Daily Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. [Full disclosures found here](=).) = --------------------------------------------------------------- [Augmedix, AUGX](=) Recent Analyst Action: Marc Wiesenberger, analyst at B.Riley Financial, reiterates coverage on [Augmedix (AUGX)](in the Services sector with a Buy rating and a price target of $4.5 (1 month ago). - Recent Price: $2.08 - Average Analyst Price Target: $4.25 (104.33%) - Market Cap: $77.46M [TipRanks.com]( also reports that [Augmedix](=)currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $4.25. The target pricing ranges from a high forecast of $4.50 down to a low forecast of $4.00. [Augmedix (AUGX)](=)’s last closing price was $2.08 which would put the average price target at $4.25. Here are 3rd party ratings for [AUGX](): - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Top 39% (97 out of 251) [Click here for chart >>](=) -------------------------------------------------------------------------- [Nordic American Tanker, NAT]( Recent Analyst Action: Omar Nokta, analyst at Jefferies, reiterates coverage on [Nordic American Tanker (NAT)](in the Industrial Goods sector with a Buy rating and a price target of $4.00 (3 days ago). - Recent Price: $3.175 - Average Analyst Price Target: $3.08 (-2.99%) - Market Cap: $619.14M [TipRanks.com]() also reports that [Nordic American Tanker]()currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $3.08. The target pricing ranges from a high forecast of $4.00 down to a low forecast of $2.40. [Nordic American Tanker (NAT)]()’s last closing price was $3.175 which would put the average price target at $3.08. Here are 3rd party ratings for [NAT](): - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 20% (49 out of 251) [Click here for chart >>]() -------------------------------------------------------------------------- --------------------------------------------------------------- [Write These Three Ticker Symbols Down](=) =According to millionaire trader Jeff Clark, the stocks marked in this proprietary calendar are pre-determined to see big moves any day… all thanks to federal law 73-291. In his testing, he already doubled his money in 45 minutes with this strategy. And now he revealed the names of three of those stocks, completely free. [Click here to see the details and write them down.]( = --------------------------------------------------------------- [Wingstop, WING]( Recent Analyst Action: David Tarantino, analyst at Robert W. Baird, reiterates coverage on [Wingstop (WING)]()in the Services sector with a Buy rating (3 weeks ago). - Recent Price: $146.06 - Average Analyst Price Target: $127.42 (-12.76%) - Market Cap: $4.35B [TipRanks.com]() also reports that [Wingstop]()currently has 13 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $127.42. The target pricing ranges from a high forecast of $150.00 down to a low forecast of $70.00. [Wingstop (WING)](’s last closing price was $146.06 which would put the average price target at $127.42. Here are 3rd party ratings for [WING](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Bottom 27% (182 out of 251) [Click here for chart >>](=) -------------------------------------------------------------------------- [Finch Therapeutics Group, FNCH](=) Recent Analyst Action: Vernon Bernardino, analyst at H.C. Wainwright, reiterates coverage on [Finch Therapeutics Group (FNCH)](in the Healthcare sector with a Buy rating and a price target of $17.00 (3 weeks ago). - Recent Price: $2.65 - Average Analyst Price Target: $17.00 (541.51%) - Market Cap: $125.42M [TipRanks.com]( also reports that [Finch Therapeutics Group](=)currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $17.00. The target pricing ranges from a high forecast of $17.00 down to a low forecast of $17.00. [Finch Therapeutics Group (FNCH)](=)’s last closing price was $2.65 which would put the average price target at $17.00. Here are 3rd party ratings for [FNCH](=): - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Buy, Top 32% (80 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast: ["Prepare for Five Years of Famine"]() [Click here]() for the name of the one ticker you need to protect yourself. --------------------------------------------------------------- And there you have it--7 Five Day Gainers of all US Exchanges. Sincerely, The Editor, MarketSectorDaily.com [Unsubscribe]( Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954 If you no longer wish to receive our emails, click the link below: [Unsubscribe]( MarketSectorDaily.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane Mooresville, North Carolina 28115 United States 184580309540